ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions
Université de Strasbourg · NYU Langone Health · +36 more institutions
Abstract
In 2017, the International League Against Epilepsy (ILAE) Classification of Epilepsies described the "genetic generalized epilepsies" (GGEs), which contained the "idiopathic generalized epilepsies" (IGEs). The goal of this paper is to delineate the four syndromes comprising the IGEs, namely childhood absence epilepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy, and epilepsy with generalized tonic-clonic seizures alone. We provide updated diagnostic criteria for these IGE syndromes determined by the expert consensus opinion of the ILAE's Task Force on Nosology and Definitions (2017-2021) and international external experts outside our Task Force. We incorporate current knowledge from recent advances…
Citation impact
- FWCI
- 55.25
- Percentile
- 100%
- References
- 149
Authors
22- ÉHÉdouard Hirsch
Université de Strasbourg
- JAJacqueline A. French
NYU Langone Health, New York University
- IEIngrid E. Scheffer
Royal Children's Hospital, Florey Institute of Neuroscience and Mental Health, Murdoch Children's Research Institute
- ABAlicia Bogacz
Universidad de la República de Uruguay, Universidad de Montevideo
- TATaoufik Alsaadi
Emirates Foundation
Topics & keywords
- Juvenile myoclonic epilepsy
- Idiopathic generalized epilepsy
- Nosology
- Epilepsy
- Psychology
- Medicine
- Neuroscience
- Childhood absence epilepsy
Funding
- UDU.S. Department of DefenseAwards: W81XWH, W81XWH-18, W81XWH-18-1-0612
- ELEli Lilly and Company
- PPfizer
- GGlaxoSmithKline
- SSanofi
- BBiogen
- GHGenomic Health
- UOUniversity of Calgary
- MMedicure
- SSunovion
- ZZogenix
- UPUltragenyx Pharmaceutical
- LLivaNova
- GPGW Pharmaceuticals
- ZPZynerba Pharmaceuticals
- SLSK Life Science
- EREpilepsy Research UK
- TTenovus
- UOUniversity of Cambridge
- UOUniversity of Oxford
- ECEuropean Commission
- ASAustrian Science Fund
- EEisai
- BFBundesministerium für Wissenschaft und Forschung
- ENEVER Neuro Pharma
- AIAlberta Innovates
- GPG.L. Pharma
- HLH. Lundbeck A/S
- EEpilepsiatutkimussäätiö
- NNeuraxpharm
- ATArvelle Therapeutics
- SSeqirus
- NINational Institutes of HealthAwards: U54 NS100064, NS100064, W81XWH, NS43209
- CSCumming School of Medicine, University of Calgary
- CICanadian Institutes of Health Research
- MRMedical Research CouncilAward: U54 NS100064
- NHNational Health and Medical Research Council
- UPUCB Pharma
- CCilag